Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial
about
Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer.PharmGKB summary: voriconazole pathway, pharmacokinetics.Genetic polymorphisms of CYP3A4 among Chinese patients with steroid-induced osteonecrosis of the femoral head.Circadian genes and risk of prostate cancer in the prostate cancer prevention trial.
P2860
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Finasteride concentrations and ...... ostate Cancer Prevention Trial
@ast
Finasteride concentrations and ...... ostate Cancer Prevention Trial
@en
Finasteride concentrations and ...... ostate Cancer Prevention Trial
@nl
type
label
Finasteride concentrations and ...... ostate Cancer Prevention Trial
@ast
Finasteride concentrations and ...... ostate Cancer Prevention Trial
@en
Finasteride concentrations and ...... ostate Cancer Prevention Trial
@nl
prefLabel
Finasteride concentrations and ...... ostate Cancer Prevention Trial
@ast
Finasteride concentrations and ...... ostate Cancer Prevention Trial
@en
Finasteride concentrations and ...... ostate Cancer Prevention Trial
@nl
P2093
P2860
P1433
P1476
Finasteride concentrations and ...... ostate Cancer Prevention Trial
@en
P2093
Ann W Hsing
Ashraful Hoque
Cathee Till
Catherine M Tangen
Cindy H Chau
Douglas K Price
Howard L Parnes
Ian M Thompson
Jeannette M Schenk
P2860
P304
P356
10.1371/JOURNAL.PONE.0126672
P407
P577
2015-01-01T00:00:00Z